Patient safety is of utmost importance to Aspar Pharmaceuticals.

Pharmacovigilance relates to the detection, assessment, understanding and prevention of the adverse effects or any other drug related problems.
While medicines have led to major improvement in the treatment and control of disease, all may cause side effects in some people.

Company Responsibilities

Aspar Pharmaceuticals is responsible for the continued monitoring of the safety of their products. To manage these responsibilities companies must fulfil a number of obligations including the collection and investigation of information relating to side-effects of their medicines, and reporting adverse events to the regulatory authorities within strict timelines.

Information from spontaneous reports provided by health professionals and patients is of great value during the regular reviews of the safety profile of Aspar products, and enables the provision of a better service to health professionals and patients enquiring about side-effects and toxicity.

Report a problem

To report an adverse experience with a specific Aspar product, please call the Aspar 24hr Service Center on 07546 693873

Along with MHRA (Medicines and Healthcare products Regulatory Agency) guidelines, Aspar has put in place a 24hr help and advisory service that is accessible via phone or email, please refer to the information below.

The information service is available to individual patients, the medical profession, and emergency services.

Please note that in the case of contact from individual members of the public we are not able to prescribe or supply drugs, nor can we offer individual diagnoses you should always seek the advice of your doctor or pharmacist as soon as is practical for you to do so.